Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are Cannabis-Based Medicines Included in Anxiety Treatment Guidelines? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

The role of cannabis in formal treatment frameworks is evolving. Cannabis medicines for anxiety  guidelines examine whether products like Sativex/CBD oil are recognised in clinical protocols. Understanding guideline inclusion and their place in established care pathways helps clinicians and patients make informed decisions about therapeutic options. 

What can I treat with Medical Cannabis?

Integration of Cannabis Medicines 

Reviewing cannabis medicines for anxiety guidelines clarifies how these therapies fit within broader treatment strategies. 

Sativex/CBD Oil 

Certain formulations, including Sativex/CBD oil, have shown promise for anxiety-related symptoms in studies, but their inclusion in official guidelines remains limited. 

Guideline Inclusion 

Guideline inclusion is currently cautious, with most national frameworks recommending standard interventions first and considering cannabis-based medicines only under specialist supervision or in research contexts. 

Care Pathways 

Within care pathways, cannabis-based therapies may be explored for patients who do not respond to conventional treatments, offering an adjunctive option rather than first-line therapy. 

Personalised Considerations 

Clinicians can reference cannabis medicines for anxiety guidelines to determine when products like Sativex/CBD oil might be appropriate, aligning with evidence, patient needs, and regulatory considerations. 

Understanding cannabis medicines for anxiety guidelines, including Sativex/CBD oil, guideline inclusion, and care pathways, helps ensure safe, informed use. While promising, cannabis-based medicines remain adjunctive in most frameworks, emphasising the importance of professional guidance and evidence-based decision-making. 

If you’re exploring cannabis treatment options for anxiety disorders, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and anxiety disorders. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories